Andrew Booth - 31 Dec 2021 Form 5 Insider Report for AbCellera Biologics Inc. (ABCL)

Role
Chief Financial Officer
Signature
/s/ Tryn Stimart, attorney-in-fact
Issuer symbol
ABCL
Transactions as of
31 Dec 2021
Net transactions value
$0
Form type
5
Filing time
03 Feb 2022, 17:54:26 UTC
Previous filing
10 Dec 2021
Next filing
16 May 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ABCL Common Shares Gift $0 -500,000 -90% $0.000000 53,500 10 Dec 2021 Direct F1
holding ABCL Common Shares 130,959 31 Dec 2021 By spouse
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This transaction represents a charitable donation of 500,000 common shares the reporting person donated on December 10, 2021.